Literature DB >> 21782046

The human histone H3 complement anno 2011.

Thomas H A Ederveen1, Imke K Mandemaker, Colin Logie.   

Abstract

Histones are highly basic, relatively small proteins that complex with DNA to form higher order structures that underlie chromosome topology. Of the four core histones H2A, H2B, H3 and H4, it is H3 that is most heavily modified at the post-translational level. The human genome harbours 16 annotated bona fide histone H3 genes which code for four H3 protein variants. In 2010, two novel histone H3.3 protein variants were reported, carrying over twenty amino acid substitutions. Nevertheless, they appear to be incorporated into chromatin. Interestingly, these new H3 genes are located on human chromosome 5 in a repetitive region that harbours an additional five H3 pseudogenes, but no other core histone ORFs. In addition, a human-specific novel putative histone H3.3 variant located at 12p11.21 was reported in 2011. These developments raised the question as to how many more human histone H3 ORFs there may be. Using homology searches, we detected 41 histone H3 pseudogenes in the current human genome assembly. The large majority are derived from the H3.3 gene H3F3A, and three of those may code for yet more histone H3.3 protein variants. We also identified one extra intact H3.2-type variant ORF in the vicinity of the canonical HIST2 gene cluster at chromosome 1p21.2. RNA polymerase II occupancy data revealed heterogeneity in H3 gene expression in human cell lines. None of the novel H3 genes were significantly occupied by RNA polymerase II in the data sets at hand, however. We discuss the implications of these recent developments. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782046     DOI: 10.1016/j.bbagrm.2011.07.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

2.  Nucleosomal regulation of chromatin composition and nuclear assembly revealed by histone depletion.

Authors:  Christian Zierhut; Christopher Jenness; Hiroshi Kimura; Hironori Funabiki
Journal:  Nat Struct Mol Biol       Date:  2014-06-22       Impact factor: 15.369

Review 3.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

4.  Canonical and Variant Forms of Histone H3 Are Deposited onto the Human Cytomegalovirus Genome during Lytic and Latent Infections.

Authors:  Emily R Albright; Robert F Kalejta
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

5.  Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas.

Authors:  Sriram Venneti; Mihir T Garimella; Lisa M Sullivan; Daniel Martinez; Jason T Huse; Adriana Heguy; Mariarita Santi; Craig B Thompson; Alexander R Judkins
Journal:  Brain Pathol       Date:  2013-03-06       Impact factor: 6.508

6.  EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.

Authors:  Rong Lian; Huimin Ma; Zhiyan Wu; Guozheng Zhang; Lei Jiao; Wenjie Miao; Qianqian Jin; Ruixue Li; Ping Chen; Haixu Shi; Wenfa Yu
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

7.  The genomic landscape of pediatric acute lymphoblastic leukemia.

Authors:  Samuel W Brady; Kathryn G Roberts; Zhaohui Gu; Lei Shi; Stanley Pounds; Deqing Pei; Cheng Cheng; Yunfeng Dai; Meenakshi Devidas; Chunxu Qu; Ashley N Hill; Debbie Payne-Turner; Xiaotu Ma; Ilaria Iacobucci; Pradyuamna Baviskar; Lei Wei; Sasi Arunachalam; Kohei Hagiwara; Yanling Liu; Diane A Flasch; Yu Liu; Matthew Parker; Xiaolong Chen; Abdelrahman H Elsayed; Omkar Pathak; Yongjin Li; Yiping Fan; J Robert Michael; Michael Rusch; Mark R Wilkinson; Scott Foy; Dale J Hedges; Scott Newman; Xin Zhou; Jian Wang; Colleen Reilly; Edgar Sioson; Stephen V Rice; Victor Pastor Loyola; Gang Wu; Evadnie Rampersaud; Shalini C Reshmi; Julie Gastier-Foster; Jaime M Guidry Auvil; Patee Gesuwan; Malcolm A Smith; Naomi Winick; Andrew J Carroll; Nyla A Heerema; Richard C Harvey; Cheryl L Willman; Eric Larsen; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Stuart S Winter; Michael J Burke; Wanda Salzer; Kimberly P Dunsmore; Anne L Angiolillo; Kristine R Crews; James R Downing; Sima Jeha; Ching-Hon Pui; William E Evans; Jun J Yang; Mary V Relling; Daniela S Gerhard; Mignon L Loh; Stephen P Hunger; Jinghui Zhang; Charles G Mullighan
Journal:  Nat Genet       Date:  2022-09-01       Impact factor: 41.307

8.  Recurrent H3.3 alterations in childhood tumors.

Authors:  Anders M Lindroth; Christoph Plass
Journal:  Nat Genet       Date:  2013-12       Impact factor: 38.330

9.  Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.

Authors:  Yong Yu; Kolja Schleich; Bin Yue; Sujuan Ji; Philipp Lohneis; Kristel Kemper; Mark R Silvis; Nouar Qutob; Ellen van Rooijen; Melanie Werner-Klein; Lianjie Li; Dhriti Dhawan; Svenja Meierjohann; Maurice Reimann; Abdel Elkahloun; Steffi Treitschke; Bernd Dörken; Christian Speck; Frédérick A Mallette; Leonard I Zon; Sheri L Holmen; Daniel S Peeper; Yardena Samuels; Clemens A Schmitt; Soyoung Lee
Journal:  Cancer Cell       Date:  2018-02-12       Impact factor: 31.743

10.  DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin.

Authors:  Erwan Delbarre; Kristina Ivanauskiene; Thomas Küntziger; Philippe Collas
Journal:  Genome Res       Date:  2012-12-05       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.